Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol

Research output: Contribution to journal › Research article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{182b2239778a4a7dbc920e075ade730a,

title = "Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol",

author = "A Scherlacher and R Jakse and M Lehnert",

year = "1985",

doi = "10.1055/s-2007-1008087",

language = "Deutsch ({\"O}sterreich)",

journal = "Laryngo- Rhino- Otologie",

issn = "0935-8943",

publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - Therapy of recurrent squamous cell cancers in the ENT area with the sequential methotrexate (MTX)/5-fluorouracil (5-Fu) protocol

AU - Scherlacher, A

AU - Jakse, R

AU - Lehnert, M

PY - 1985

Y1 - 1985

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:A1985ACR4000002

UR - https://pubmed.ncbi.nlm.nih.gov/3872391

U2 - 10.1055/s-2007-1008087

DO - 10.1055/s-2007-1008087

M3 - Originalarbeit

C2 - 3872391

SN - 0935-8943

JO - Laryngo- Rhino- Otologie

JF - Laryngo- Rhino- Otologie

ER -